共 216 条
- [1] Molina J-M(2015)On-demand preexposure prophylaxis in men at high risk for HIV-1 infection N Engl J Med 373 2237-2246
- [2] Capitant C(2017)Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study Lancet HIV 4 e402-e410
- [3] Spire B(2016)Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial Lancet 387 53-60
- [4] Pialoux G(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599
- [5] Cotte L(2013)Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: Lessons learned from trials and treatment studies Am J Prev Med 44 S91-S98
- [6] Charreau I(2012)Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men Sci Transl Med 4 151ra125-348
- [7] Molina JM(2014)HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention J Acquir Immune Defic Syndr 66 340-155
- [8] Charreau I(2011)Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP) PLoS ONE 61 133-209
- [9] Spire B(2019)Supporting adherence to medicines for long-term conditions Eur Psychol 42 200-567
- [10] Cotte L(2005)Resisting medicines: a synthesis of qualitative studies of medicine taking Soc Sci Med 16 18640-24